STATIN-FIBRATE REPORT: Focus on Safety

However, although there are no data to support a “treatment” triglyceride level in which patients would obtain the most benefit, several authors have recommended the statin-fibrate combination be considered in a patient with mixed dyslipidemia (LDL-C >100 mg/dl, HDL-C ................
................